🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Christian P. Kratz

Medizinische Hochschule Hannover

ORCID: 0000-0003-4120-5873
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
4.6Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The TP53 Database: transition from the International Agency for Research on Cancer to the US National Cancer Institute

Cell Death and Differentiation(2022)10.1038/s41418-022-00976-3
Top 6%
4.0DataRank
Top 6%167 citations

Elaine E. Lee, Elise M. Tookmanian, Chimene Kesserwan, James J. Manfredi, Jessica N. Hatton +12 more

Papers

Driven by 14 papers — median percentile 82. Top paper: “The TP53 Database: transition from the International Agency for Research on Cancer to the US National Cancer Institute”.

The TP53 Database: transition from the International Agency for Research on Cancer to the US National Cancer Institute

Cell Death and Differentiation(2022)10.1038/s41418-022-00976-3
Top 6%
4.0DataRank
Top 6%167 citations

Elaine E. Lee, Elise M. Tookmanian, Chimene Kesserwan, James J. Manfredi, Jessica N. Hatton +12 more

Clinical outcome of pediatric medulloblastoma patients with Li–Fraumeni syndrome

Neuro-Oncology(2023)10.1093/neuonc/noad114
Top 30%
0.654DataRank
Top 30%22 citations

Léa Guerrini‐Rousseau, Julien Masliah-Planchon, Jonas Ecker, Florian Selt, Martin Mynarek +68 more

Update on Pediatric Cancer Surveillance Recommendations for Patients with Neurofibromatosis Type 1, Noonan Syndrome, CBL Syndrome, Costello Syndrome, and Related RASopathies

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1611
N/A
0.524DataRank · unranked
32 citations

Anirban Das, Sarah Scollon, Sarah G. Mitchell, Mary‐Louise C. Greer, Marielle E. Yohe +22 more

Adult-Onset Cancer Predisposition Syndromes in Children and Adolescents—To Test or not to Test?

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3683
N/A
0.477DataRank · unranked
23 citations

Philip J. Lupo, Kristin Zelley, Jaclyn Schienda, Kim E. Nichols, Douglas R. Stewart +6 more

Update on Cancer and Central Nervous System Tumor Surveillance in Pediatric NF2 -, SMARCB1 -, and LZTR1 -Related Schwannomatosis

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3278
N/A
0.373DataRank · unranked
11 citations

Marjolijn C.J. Jongmans, Gail E. Tomlinson, Mary‐Louise C. Greer, Sarah Scollon, Sarah G. Mitchell +18 more

Unusual phenotypes in patients with a pathogenic germline variant in DICER1

Familial Cancer(2021)10.1007/s10689-021-00271-z
N/A
0.373DataRank · unranked
11 citations

Miriam Elbracht, Julia Carlens, Peter Deutz, Felix Zeppernick, Lisa Lassay +10 more

PTPN11 Mutational Spectrum in Juvenile Myelomonocytic Leukemia and Noonan Syndrome.

Blood(2004)10.1182/blood.v104.11.3417.3417
N/A
0.104DataRank · unranked
1 citations

Charlotte M. Niemeyer, Bruce D. Gelb, Marco Tartaglia, Mignon L. Loh, Christian P. Kratz

Update on Recommendations for Cancer Screening and Surveillance in Children with Genomic Instability Disorders

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1098
N/A
0DataRank · unranked
23 citations

Roland P. Kuiper, Kim E. Nichols, Christopher C. Porter, Harry Lesmana, Julia Meade +13 more

Cancer incidence and surveillance strategies in individuals withRASopathies

American Journal of Medical Genetics Part C Seminars in Medical Genetics(2022)10.1002/ajmg.c.32018
N/A
0DataRank · unranked
25 citations

Andrea M. Gross, Alicia A. Livinski, Christian P. Kratz, Douglas R. Stewart, Gina M. Ney

Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility

Human Genetics and Genomics Advances(2023)10.1016/j.xhgg.2023.100244
N/A
0DataRank · unranked
7 citations

Cíntia Fridman, Bonald C. Figueiredo, Hector Salvador, Manuel R. Teixeira, Carla Pinto +23 more

A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era

Cancer Discovery(2021)10.1158/2159-8290.cd-21-1094
N/A
0DataRank · unranked
199 citations

Miguel Reyes‐Múgica, John K. C. Chan, Henrik Hasle, Alexander J. Lazar, Sabrina Rossi +12 more

A quantitative, Bayesian-informed approach to gene-specific variant classification: Updated Expert Panel recommendations improve classification of TP53 germline variants for Li-Fraumeni syndrome

Genome Medicine(2025)10.1186/s13073-025-01536-3
N/A
0DataRank · unranked
5 citations

Megan N. Frone, Jessica L. Mester, Miguel de la Hoya, Phuong L. Mai, Tina Pesaran +32 more

Neoantigenic properties of TP53 variants influence cancer risk in individuals with Li-Fraumeni syndrome

EBioMedicine(2025)10.1016/j.ebiom.2025.106065
N/A
0DataRank · unranked
2 citations

Olivier Manches, Jonathan Gaucher, Claire Freyçon, D B Collantes Hoyos, Sandrine Blanchet +14 more

Comprehensive investigation of DNA damage repair genes in children with cancer identifies SMARCAL1 as novel osteosarcoma predisposition gene

medRxiv(2025)10.1101/2025.05.12.25325832
N/A
0DataRank · unranked
0 citations

Wenan Chen, Alise Blake, Lynn Harrison, Martha A. O’Brien, Christopher Previti +25 more